HD-OPM Archive
Hashtags

#statinscancer

12 posts

Low LDL in cancer patients reflects reverse causality: tumours scavenge LDL

May 25, 2026 · Louis Nervegna ♥ 17 · 💬 12 LDL, ApoB & lipid panel

Louis explains that rapidly dividing tumour cells take up circulating LDL, so LDL falls in people with cancer and observational data show low LDL with higher cancer mortality. The shared 2026 Science Advances study found aggressive breast cancers with TP53 mutations depend on cholesterol, and blocking PI5P4K enzymes trapped cholesterol and disrupted mTOR signalling.

Statin plus sildenafil may block cancer metastasis in preclinical models

Jul 27, 2026 · Louis Nervegna ♥ 16 · 💬 4 Cancer

A 2026 Cancer Research study found sildenafil (a PDE5 inhibitor) caused cholesterol to accumulate in lysosomes of mouse and human cancer models, limiting cholesterol available to cancer cells and impairing their migration and spread. Combining it with a statin, which blocks cholesterol production, gave stronger anti-metastatic effects than either alone. Louis notes the research is preclinical but promising.

Isoleucine and valine fuel prostate cancer by boosting tumor cholesterol

Aug 26, 2026 · Louis Nervegna ♥ 7 · 💬 9 Cancer

Louis notes that isoleucine, valine and methionine shorten mouse lifespan, and a 2026 Nature Metabolism study links isoleucine and valine to prostate cancer progression. Their breakdown produces propionyl-CoA, which enhances the cancer cells' cholesterol synthesis, transport and storage, supplying lipids for growth.

Low LDL's link to cancer is reverse causality: cancer lowers cholesterol, not vice versa

Dec 21, 2023 · Louis Nervegna ♥ 5 · 💬 1 LDL, ApoB & lipid panel

Louis explains why observational studies linking low LDL to cancer are not causal. Citing a Circulation review on reverse causality, he notes cholesterol declines before cancer diagnosis (likely from cancer-related inflammation), statin RCTs show no increase in cancer, and Mendelian randomization with an average of 52 years of lifetime exposure shows no higher cancer rates in people with genetically lower cholesterol.

Statin use linked to 35% lower odds of liver cancer in UK database study

Sep 15, 2026 · Louis Nervegna ♥ 10 Statins

A UK Clinical Practice Research Datalink case-control study of 3,719 liver cancer cases and 14,876 controls found statin users had 35% lower odds of liver cancer, and cholesterol absorption inhibitors (ezetimibe class) 31% lower odds. This is an association, not proof, and non-statin findings need replication.